TRILLIUM THERAPEUTICS INC's ticker is and the CUSIP is 89620X506. A total of 19 filers reported holding TRILLIUM THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $166,000 | -27.2% | 15,500 | 0.0% | 0.03% | -27.7% |
| Q4 2020 | $228,000 | -67.5% | 15,500 | -82.1% | 0.05% | -77.1% |
| Q2 2020 | $702,000 | -58.4% | 86,757 | -79.2% | 0.20% | -63.7% |
| Q1 2020 | $1,687,000 | -40.5% | 417,577 | -84.8% | 0.56% | -16.3% |
| Q4 2019 | $2,834,000 | – | 2,751,186 | – | 0.68% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AWM Investment Company, Inc. | 701,138 | $4,067,000 | 0.67% |
| Matrix Capital Management Company, LP | 2,288,560 | $13,274,000 | 0.33% |
| NEA Management Company, LLC | 1,250,000 | $7,250,000 | 0.31% |
| Stanley-Laman Group, Ltd. | 139,403 | $809,000 | 0.20% |
| Cormorant Asset Management, LP | 500,000 | $2,900,000 | 0.19% |
| Tekla Capital Management LLC | 468,399 | $2,717,000 | 0.10% |
| Wealth Alliance Advisory Group, LLC | 21,800 | $126,000 | 0.06% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 175,339 | $1,007,000 | 0.03% |
| Artal Group S.A. | 150,000 | $870,000 | 0.02% |
| Baker Brothers Advisors | 505,262 | $2,931,000 | 0.02% |